International advanced wound and skin care company, Crawford Healthcare has secured the exclusive rights to Canadian advanced materials developer, Exciton Technologies’ innovative Silver Oxysalt Technology.
The deal – announced yesterday – is hoped to help establish Crawford Healthcare’s leadership in the global healthcare market in terms of aggressive antimicrobial wound treatment – a major component in the fight against antibiotic resistance.
According to Crawford Healthcare, Silver Oxysalt Technology is the only wound dressing to contain silver in its most…
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login
